Left ventricular output indices and sacubitril/valsartan titration: role of stroke volume index

Left ventricular output indices and sacubitril/valsartan titration: role of stroke volume index

Abstract Aims This study aims to investigate the role of echocardiographically determined left ventricular output indices on sacubitril/valsartan titration in a cohort of outpatients with heart failure and reduced ejection fraction (HFrEF). Methods and results We analysed 106 HFrEF patients who unde...

Full description

Saved in:

Bibliographic Details
Main Authors:	Paolo Tolomeo, Ottavio Zucchetti, Emanuele D'Aniello, Noemi Punzo, Federico Marchini, Luca Di Ienno, Elisabetta Tonet, Rita Pavasini, Claudio Rapezzi, Gianluca Campo, Matteo Serenelli
Format:	Article
Language:	English
Published:	Wiley 2022-06-01
Series:	ESC Heart Failure
Subjects:	Sacubitril Valsartan Entresto HFrEF Titration
Online Access:	https://doi.org/10.1002/ehf2.13891
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Early experience of Sacubitril–Valsartan in heart failure with reduced ejection fraction in real‐world clinical setting
by: Charlotte Nordberg Backelin, et al.
Published: (2020-06-01)

Eligibility for sacubitril–valsartan in patients with acute decompensated heart failure
by: David Carballo, et al.
Published: (2020-06-01)

Real‐world clinical diagnostics of heart failure patients with reduced or preserved ejection fraction
by: Jenni Huusko, et al.
Published: (2020-06-01)

Use of sacubitril/valsartan in non‐compaction cardiomyopathy: a case report
by: Marcely Gimenes Bonatto, et al.
Published: (2020-06-01)

Successful Management of Refractory Heart Failure and Multi-Organ Dysfunction in a Patient with CRT-D and Acute Pulmonary Edema: A Case Report
by: Marsela Goga, et al.
Published: (2025-01-01)

Effect of sacubitril/valsartan on inflammation and oxidative stress in doxorubicin-induced heart failure model in rabbits
by: Yu Chun, et al.
Published: (2021-09-01)

Progress in Managing Heart Failure: an in-depth Review of Sacubitril/Valsartan Combination Therapy
by: Neeraj Hiremath, et al.
Published: (2024-04-01)

Patterns of beta-blocker use and dose optimization among ambulatory heart failure patients with reduced ejection fraction (HFrEF) attending public hospitals in Northeast Ethiopia: a multi-center cross-sectional study
by: Minimize Hassen, et al.
Published: (2025-01-01)

Sacubitril/Valsartan for Blood Pressure Lowering in Non‐Dialysis‐Dependent Chronic Kidney Disease Stage 3–5 Patients With Hypertension: A Multicenter Clinical Study
by: Yu Yan, et al.
Published: (2025-01-01)

Sacubitril/valsartan in patients with heart failure with reduced ejection fraction with end‐stage of renal disease
by: Seonhwa Lee, et al.
Published: (2020-06-01)

The role of sacubitril/valsartan in abnormal renal function patients combined with heart failure: a meta-analysis and systematic analysis
by: Xinyue Yang, et al.
Published: (2024-12-01)

Efficacy and Safety of Sacubitril/Valsartan Versus Amlodipine in Japanese Patients With Essential Hypertension: A Randomized, Multicenter, Open‐Label, Noninferiority Study (PARASOL Study)
by: Koichi Yamamoto, et al.
Published: (2025-01-01)

Sacubitril/valsartan on right ventricular-pulmonary artery coupling and albumin-bilirubin score in heart failure in Chinese patients with reduced ejection fraction
by: Yanan Shi, et al.
Published: (2025-01-01)

Fulminant myocarditis caused by immune checkpoint inhibitor: a case report and possible treatment inspiration
by: Zhijie Liu, et al.
Published: (2022-06-01)

Spectrophotometric method for simultaneous determination of valsartan and substances from the group of statins in binary mixtures
by: Stolarczyk Mariusz, et al.
Published: (2017-12-01)

Use of compounded dispersing media for extemporaneous pediatric syrups with candesartan cilexetil and valsartan
by: Musko Monika, et al.
Published: (2014-12-01)

Determination of Acetyl Salicylic Acid in Aspirin tablets
by: Lana Mohammed Ali, et al.
Published: (2019-12-01)

Efficacy of sacubitril/valsartan among patients with chronic heart failure with reduced ejection fraction
by: Madiha Butt, et al.
Published: (2024-09-01)

Short‐term echocardiographic evaluation by global longitudinal strain in patients with heart failure treated with sacubitril/valsartan
by: Simone Mazzetti, et al.
Published: (2020-06-01)

Analysis of the Behavior of Primary School Students with CES during Physical Education Lessons
by: I.L. Constantin, et al.
Published: (2024-12-01)

Safety and Tolerability of Initiating Maximum-Dose Sacubitril-Valsartan in Patients on Target Dose Renin-Angiotensin System Inhibitors
by: Helena Norberg, et al.
Published: (2019-01-01)

Sacubitril/valsartan is associated with improvements in quality of life in adult congenital heart disease patients with systemic right ventricular failure
by: Philippine Kiès, et al.
Published: (2025-01-01)

Thermodynamic investigations on host/guest complexation in deep eutectic solvent/water mixtures
by: Nakhle, Lamia, et al.
Published: (2024-04-01)

Teachers’ perspective on the use of artificial intelligence on remote experimentation
by: Fiorella Lizano-Sánchez, et al.
Published: (2025-02-01)

The effects of pulse amplitude in electroconvulsive therapy on seizure threshold, seizure duration, and time to reorientation
by: Maya Hazimeh, et al.
Published: (2025-03-01)

Activity and diffusivity of oxygen in the liquid dilute BixSb1-x solutions
by: Jendrzejczyk-Handzlik D., et al.
Published: (2018-01-01)

Structural requirements and interaction mechanisms of ACE inhibitory peptides: molecular simulation and thermodynamics studies on LAPYK and its modified peptides
by: Biying Zhang, et al.
Published: (2022-11-01)

Variation in clinical and patient‐reported outcomes among complex heart failure with preserved ejection fraction phenotypes
by: Kelsey M. Flint, et al.
Published: (2020-06-01)

Phenotypic Trajectories From Acute to Stable Phase in Heart Failure With Preserved Ejection Fraction: Insights From the PURSUIT‐HFpEF Study
by: Yuki Matsuoka, et al.
Published: (2025-02-01)

Molecular Mechanism of Targeted Inhibition of Pancreatic Lipase and Cholesterol Esterase by Hempseed Peptides
by: YIN Hao, ZHU Jiangxiong, ZHAO Haiyun, ZHONG Yu, WANG Danfeng, DENG Yun
Published: (2025-01-01)

The HFA‐PEFF score identifies ‘early‐HFpEF’ phenogroups associated with distinct biomarker profiles
by: Michiel T.H.M. Henkens, et al.
Published: (2022-06-01)

Relation of left atrial overload indices with prognostic endpoints in heart failure and preserved ejection fraction
by: Shiro Hoshida, et al.
Published: (2022-06-01)

Single-cell transcriptomic profiling of heart reveals ANGPTL4 linking fibroblasts and angiogenesis in heart failure with preserved ejection fraction
by: Guoxing Li, et al.
Published: (2025-02-01)

Analysis of the Variation of Vitamin C Content in Different Varieties of Passion Fruits from Kabale Central Market
by: Ssenoga, Regan
Published: (2022)

Mural cell dysfunction contributes to diastolic heart failure by promoting endothelial dysfunction and vessel remodelling
by: Mandy O. J. Grootaert, et al.
Published: (2025-02-01)

Ecological footprint of university students: Does gender matter?
by: M.A. Medina, et al.
Published: (2016-12-01)

Caloric restriction and its mimetics in heart failure with preserved ejection fraction: mechanisms and therapeutic potential
by: Alexander Fuerlinger, et al.
Published: (2025-01-01)

Protocol for recombinant rabies virus titration by quantitative PCR
by: He Zhang, et al.
Published: (2025-03-01)

Mind over matter: consistency monitoring and domain-specific learning
by: Igor Bascandziev, et al.
Published: (2025-02-01)

PHYTOCHEMICAL ANALYSIS OF SEVERAL CULTIVARS OF ARONIA MELANOCARPA FROM THE COLLECTION OF THE "ALEXANDRU CIUBOTARU" NATIONAL BOTANICAL GARDEN (INSTITUTE)
by: Ion Roșca, et al.
Published: (2024-08-01)